Chelation therapy is an amino acid (Ethylenediaminetetracetic acid) EDTA that was first used in the 1940’s for treatment of heavy metal toxicity. Since the 1960’s it has been recognized for its benefit for occlusive vascular disease caused by atherosclerosis (hardening of the arteries). It is administered intravenously (IV) by slow drip into a vein.

Since the 1960’s, clinical experience with EDTA has convinced substantial numbers of licensed physicians in North America that it is a safe and effective treatment for atherosclerotic vascular disease (especially when combined with a healthy diet, nutritional supplementation, as well as following a healthy lifestyle). It has been found to consistently improve blood flow and relieve symptoms associated with atherosclerosis. It is reported that more than 80% of the patients who adhere to the program experience significant health improvement.

What is atherosclerosis?

Atherosclerosis is also called “hardening of the arteries.” It occurs when the inner walls of the arteries become lined with deposits of fat, cholesterol, heavy metals, calcium and other substances. As plaque builds up, the arteries become hard, constricted and passages for blood flow become seriously narrowed. These changes make it difficult for blood to flow through them, so the heart must work harder to pump blood throughout the body.

If this plaque ruptures or a blood clot breaks away and blocks an artery, a heart attack, stroke, pulmonary embolism or other life-threatening problems can result. If the clot blocks a coronary artery supplying blood to the heart muscle, it is called a heart attack. A stroke occurs when an artery to the brain is blocked, and a pulmonary embolism is caused by a clot in the lung.

Doctors at our clinic belong to The American College for Advancement in Medicine (ACAM)

ACAM was founded in 1973 as a non-profit corporation and is presently comprised of approximately 750 licensed physicians, many of which are engaged in the treatment of, or research in, occlusive vascular disease and its related fields. Member physicians study and use innovative and advanced cardiovascular therapies that involve the early detection and identification of risk factors in patients and intensive education in modifying the individual patients lifestyle (diet, nutritional supplementation, exercise, habits, etc) to alter such risk factors. Among the purposes of ACAM are to advance support for and to further research in the application of EDTA chelation therapy and other sound innovative therapies for occlusive vascular disease and degenerative diseases associated with aging.